Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy

Blood Adv. 2023 May 23;7(10):2228-2236. doi: 10.1182/bloodadvances.2021006431.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Asparaginase / therapeutic use
  • Biosynthetic Pathways
  • Humans
  • Leukemia* / drug therapy

Substances

  • Asparaginase
  • Antineoplastic Agents